Champions Oncology, Inc. (CSBR) income statement
CSBRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 11, 2026Score 10/30224% above fair value
$4.40−0.04 (-0.90%)
Close on Nov 19, 2026Market cap $61.24MP/E –Yield –
Champions Oncology, Inc. financial ratios
See a number that looks wrong?